Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 46,170 shares at an average $108.28 ($4,999,230)
  3. 4 Grant or award Director acquired 4,908 shares (grant or award)
  4. 4 Grant or award Director acquired 4,908 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes SVP, General Counsel gave up 54 shares (to pay taxes)
  8. 4 Grant or award Director acquired 2,953 shares (grant or award)
  9. 4 Grant or award Director acquired 2,953 shares (grant or award)
  10. 4 Grant or award Director acquired 2,953 shares (grant or award)
  11. 4 Grant or award Director acquired 2,953 shares (grant or award)
  12. 4 Grant or award Director acquired 2,953 shares (grant or award)
  13. 4 Grant or award Director acquired 2,953 shares (grant or award)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 1,706 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP, General Counsel gave up 1,289 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP gave up 1,160 shares (to pay taxes)
  17. 4 Shares withheld for taxes Head of R&D, CSO gave up 1,216 shares (to pay taxes)
  18. 4 Shares withheld for taxes Head of R&D, CSO gave up 572 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 376 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, General Counsel gave up 184 shares (to pay taxes)

Page 9 of 34 · 672 filings